Benign prostatic hyperplasia
Chapter 14:Diseases of the genitourinary system
ICD-10 N40 is a used to indicate a diagnosis of benign prostatic hyperplasia.
Benign prostatic hyperplasia (BPH) is a common condition in older men characterized by the non-cancerous enlargement of the prostate gland. This condition can lead to urinary symptoms such as increased frequency, urgency, nocturia, and weak urine stream. BPH is significant clinically as it can affect the quality of life and may lead to complications such as urinary tract infections or bladder stones if left untreated. The diagnosis is typically made through a combination of patient history, physical examination, and possibly imaging studies or laboratory tests to rule out other conditions, including prostate cancer.
Detailed patient history, physical examination findings, results of urinalysis, and any imaging studies.
Evaluation of patients with lower urinary tract symptoms, pre-operative assessments for prostate surgery, and monitoring of BPH treatment.
Ensure differentiation from prostate cancer and other urinary disorders; document any treatment plans such as medication or surgical interventions.
Comprehensive review of patient history, medication list, and assessment of comorbid conditions affecting urinary health.
Management of chronic conditions impacting urinary symptoms, evaluation of medication side effects related to BPH.
Consider potential interactions with medications treating BPH and other chronic illnesses; document patient education provided.
Assessment of renal function tests, patient history regarding urinary tract infections, and any imaging findings.
Management of patients with BPH experiencing renal impairment or recurrent urinary tract infections.
Monitor for potential kidney complications arising from urinary obstruction; document any referrals to urology.
Indications for the procedure, findings during cystoscopy, and any interventions performed.
Document patient symptoms, the reason for urinalysis, and results.
Indications for the procedure, findings, and any abnormalities noted.
Document the reason for the injection, dosage, and any patient response.
N40 specifically includes benign prostatic hyperplasia, which may manifest with various urinary symptoms but does not include malignant conditions or prostatitis.
N40 codes should be used when a patient is diagnosed with benign prostatic hyperplasia, particularly when they present with symptoms affecting urinary function.
Documentation should include a clear diagnosis of benign prostatic hyperplasia, details of the patient's symptoms, any relevant test results, and the treatment plan.
